TSE Panel Comments On Tissue Decontamination Protocols, Pooled Samples
This article was originally published in The Gray Sheet
Executive Summary
FDA should develop specific protocols for mitigating the transmission of Creutzfeld-Jakob disease and viral CJD in human cells, tissues and cellular and tissue-based products (HCT/Ps) for evaluation by the Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC) at a future meeting, TSEAC voted June 26